Documentation Centre

 

 

  of 619 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study. Metabolism. 2022;133:155220 November 14, 2022 Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study. Metabolism. 2022;133:155220 Peng H, Wang S, Wang M, Ye Y, Xue E, Chen X, Wang X, Fan M, Gao W, Qin X, Wu Y, Chen D, Li J, Hu Y, Wang L, Wu T Key Publications
Caffeine consumption and cardiovascular health. Nat Rev Cardiol. 2022;19:429-430 November 10, 2022 Caffeine consumption and cardiovascular health. Nat Rev Cardiol. 2022;19:429-430 van Dam RM, Hu FB Key Publications
Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations. Nat Rev Endocrinol. 2022;18:413-432 November 09, 2022 Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations. Nat Rev Endocrinol. 2022;18:413-432 Ke C, Narayan KMV, Chan JCN, Jha P, Shah BR Key Publications
Epigenetics of type 2 diabetes mellitus and weight change - a tool for precision medicine? Nat Rev Endocrinol. 2022;18:433-448 November 09, 2022 Epigenetics of type 2 diabetes mellitus and weight change - a tool for precision medicine? Nat Rev Endocrinol. 2022;18:433-448 Ling C, Bacos K, Rönn T Key Publications
Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective. Atherosclerosis. 2022;349:7-16 September 14, 2022 Lipoprotein(a) and cardiovascular and valvular diseases: A genetic epidemiological perspective. Atherosclerosis. 2022;349:7-16 Arsenault BJ, Kamstrup PR. Key Publications
Lipoprotein (a) and diabetes mellitus. Atherosclerosis. 2022;349:63-71 September 14, 2022 Lipoprotein (a) and diabetes mellitus. Atherosclerosis. 2022;349:63-71 Lamina C, Ward NC Key Publications
Prediction of incident atherosclerotic cardiovascular disease with polygenic risk of metabolic disease: Analysis of 3 prospective cohort studies in Korea. Atherosclerosis. 2022;348:16-24 September 01, 2022 Prediction of incident atherosclerotic cardiovascular disease with polygenic risk of metabolic disease: Analysis of 3 prospective cohort studies in Korea. Atherosclerosis. 2022;348:16-24 Song H, Koh Y, Rhee TM, Choi SY, Kang S, Lee SP Key Publications
Associations between body composition, fat distribution and metabolic consequences of excess adiposity with severe COVID-19 outcomes: observational study and Mendelian randomisation analysis. Int J Obes (Lond). 2022;46:943-950 August 25, 2022 Associations between body composition, fat distribution and metabolic consequences of excess adiposity with severe COVID-19 outcomes: observational study and Mendelian randomisation analysis. Int J Obes (Lond). 2022;46:943-950 Gao M, Wang Q, Piernas C, Astbury NM, Jebb SA, Holmes MV, Aveyard P Key Publications
Clinical utility of polygenic risk scores for coronary artery disease. Nat Rev Cardiol. 2022;19:291-301 August 24, 2022 Clinical utility of polygenic risk scores for coronary artery disease. Nat Rev Cardiol. 2022;19:291-301 Klarin D, Natarajan P Key Publications
How communicating polygenic and clinical risk for atherosclerotic cardiovascular disease impacts health behavior: an observational follow-up study. Circ Genom Precis Med. 2022;15:e003459 August 24, 2022 How communicating polygenic and clinical risk for atherosclerotic cardiovascular disease impacts health behavior: an observational follow-up study. Circ Genom Precis Med. 2022;15:e003459 Widén E, Junna N, Ruotsalainen S, Surakka I, Mars N, Ripatti P, Partanen JJ, Aro J, Mustonen P, Tuomi T, Palotie A, Salomaa V, Kaprio J, Partanen J, Hotakainen K, Pöllänen P, Ripatti S Key Publications

  of 619 Next page

Go to page: of